Biotech Investors & VC Firms in United States
1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.
3x5 Partners
Portland
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
10x Genomics
Pleasanton
4 people
Neue Fund
Miami BeachPre-Seed–Series A$50K – $100K
West Virginia Jobs Investment Trust
CharlestonSeed–Late Stage$100K – $1M
Sila B Health Ventures
Foster CitySeed–Series A$100K – $500K
Pittsburgh Life Sciences Greenhouse
PittsburghSeed–Series B
1 person
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
New Frontier Zesty Holdings
ChicagoSeed–Series A
2 people
New Technology Ventures
Newton Lower FallsSeed–Series A
2 people
SilverArc Capital
Boston
2 people
ShangPharma Innovation
South San FranciscoSeed–Series A
2 people
Vesalius Ventures
HoustonSeed
2 people
Heritage Medical Systems
West HillsSeed
1 person
Bayside Biosciences, Inc.
Santa ClaraSeed
1 person
Genesis BioCapital
Chattanooga
1 person
LSI
New YorkPre-Seed–Seed
1 person
Sequoia Biotech Consulting
Encinitas
1 person
JAIC
Palo AltoSeed–Late Stage
Care Capital
PrincetonSeed–Growth
Remeditex Ventures
DallasSeed
Acceleris Capital
ManchesterSeed
Cartography Capital
San FranciscoPre-Seed–Seed
Fox Chase Cancer Center (Temple University)
PhiladelphiaSeed
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.









